MEDACTA GROUP S.A. SF-,10
Research MEDACTA GROUP S.A. SF-,10 (6MD) on Bullrun: market cap EUR 2.77B, P/E 29.1, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6MD
- ExchangeF
- CountrySwitzerland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 2.77B
- P/E29.1
- Dividend yield0.9%
- Financial periodFY2025
- RevenueEUR 683.83M
- Revenue growth15.8%
- Net incomeEUR 95.46M
- Free cash flowEUR 9.55M
- Gross margin67.1%
Valuation Snapshot
latest market cap is EUR 2.77B; P/E is 29.1; dividend yield is 0.9%.
Peer valuation comparison
Latest P/E is 29.14x versus a Healthcare sector median of 24.46x (19.1% above).
Latest dividend yield is 0.89% versus a Healthcare sector median of 2.11% (57.8% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 683.83M | EUR 95.46M | EUR 9.55M | 67.1% | n/a | EUR 33.21M | EUR 260.76M | EUR 456.58M |
| FY2024 | EUR 590.58M | EUR 72.89M | EUR 2.45M | 67.6% | 3.65 | EUR 31.59M | EUR 241.21M | EUR 379.66M |
| FY2023 | EUR 510.78M | EUR 47.36M | -EUR 7.09M | 68.1% | 2.37 | EUR 20.79M | EUR 201.98M | EUR 330.04M |
| FY2022 | EUR 437.12M | EUR 46.25M | EUR 2.25M | 69.8% | 2.31 | EUR 32.26M | EUR 170.25M | EUR 274.66M |
| FY2021 | n/a | n/a | n/a | n/a | 2.58 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 2.77B | 29.1 | 0.9% | 1.2 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.2 EUR, yield 0.9%.
| Year | Dividends/share |
|---|---|
| FY2023 | 0.29 EUR |
| FY2022 | 0.58 EUR |
About MEDACTA GROUP S.A. SF-,10
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MEDACTA GROUP S.A. SF-,10's market cap?
MEDACTA GROUP S.A. SF-,10's market capitalization is EUR 2.77B.
What is MEDACTA GROUP S.A. SF-,10's P/E ratio?
MEDACTA GROUP S.A. SF-,10's price-to-earnings (P/E) ratio is 29.1.
Does MEDACTA GROUP S.A. SF-,10 pay a dividend?
MEDACTA GROUP S.A. SF-,10 has a dividend yield of 0.9%.
What does MEDACTA GROUP S.A. SF-,10 do?
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.